1-9 of 9
Sascha Tuchman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Therapy of Monoclonal Gammopathy of Renal Significance (MGRS)

Divaya Bhutani, Rajshekhar Chakraborty, Suzanne Lentzsch, J Christine Ye, Samuel M. Rubinstein, Sascha Tuchman, Eben I Lichtman
Journal: Blood
Blood (2024) 144 (Supplement 1): 6895.
https://doi.org/10.1182/blood-2024-210587
Published: 2024
Journal Articles

Population-Level Outcomes in Solitary Plasmacytoma: A Surveillance, Epidemiology, and End Results (SEER) Study

Daniel K Reef, Jorge A Florindez, Sascha Tuchman, Eben I Lichtman, Samuel M. Rubinstein
Journal: Blood
Blood (2024) 144 (Supplement 1): 1958.
https://doi.org/10.1182/blood-2024-211849
Published: 2024
Journal Articles

Outcomes Associated with Clone-Directed Therapies for Monoclonal Gammopathy of Renal Significance

Daniel T Peters, Jacob Amburn, Sascha Tuchman, Eben I Lichtman, Christopher Edward Jensen, Koyal Jain, Suzanne Lentzsch, Rajshekhar Chakraborty, Divaya Bhutani, Samuel M Rubinstein
Journal: Blood
Blood (2023) 142 (Supplement 1): 2027.
https://doi.org/10.1182/blood-2023-189341
Published: 2023
Journal Articles

Geriatric Assessment in Older Adults with Multiple Myeloma

Tanya M Wildes, MD, Sascha Tuchman, MD, Kathryn M. Trinkaus, Graham Colditz, MD DrPH
Journal: Blood
Blood (2016) 128 (22): 3601.
https://doi.org/10.1182/blood.V128.22.3601.3601
Published: 2016
Journal Articles

Age and Health Status Determine Treatment Receipt in Patients with Multiple Myeloma

Bita Fakhri, MD MPH, Mark A Fiala, BS, CCRP, Sascha Tuchman, MD, Tanya M Wildes, MD
Journal: Blood
Blood (2016) 128 (22): 2348.
https://doi.org/10.1182/blood.V128.22.2348.2348
Published: 2016
Journal Articles

Falls in Older Adults with Multiple Myeloma

Tanya M Wildes, MD MSCI, Mark A Fiala, BS, CCRP, Ashley E Rosko, MD, Sascha Tuchman, MD, Emily Guerard, MD, Elizabeth K. O'Donnell, MD, Erica L. Campagnaro, MD, Keith Stockerl-Goldstein, MD, Ravi Vij, MD MBA
Journal: Blood
Blood (2015) 126 (23): 4485.
https://doi.org/10.1182/blood.V126.23.4485.4485
Published: 2015
Journal Articles

A Phase I-II Study of the Combination of Bendamustine and Pomalidomide with Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma.

Cristina Gasparetto, MD, Michael Green, MD, Anandgopal Srinivasan, MDcal Student, Yubin Kang, MD, David A. Rizzieri, MD, Carlos Decastro, MD, Louis F. Diehl, MD, Anne Beaven, MD, Zighuo Li, PhD, Arati V. Rao, MD, Anderson Garrett, Sascha Tuchman, MD, Gwynn D. Long, MD
Journal: Blood
Blood (2015) 126 (23): 1857.
https://doi.org/10.1182/blood.V126.23.1857.1857
Published: 2015
Journal Articles

A Phase I Trial of Pomalidomide, Bortezomib (Velcade), and Dexamethasone (PVD) As Initial Treatment of AL Amyloidosis and Light Chain Deposition Disease

Jeffrey Zonder, MD, Christiane Houde, BS, Sascha Tuchman, MD, Vishal Kukreti, MD, Vaishali Sanchorawala, MD, Silva Pregja, MBA, Kathy A Reichel, Steven M Burt, NP, Colleen Neveux, RN, Jeffrey Matous, MD
Journal: Blood
Blood (2014) 124 (21): 4767.
https://doi.org/10.1182/blood.V124.21.4767.4767
Published: 2014
Journal Articles

Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma.

Sascha Tuchman, MD, Chaitanya Acharya, William Mostertz, William Barry, PhD, Cristina Gasparetto, MD, Bart Barlogie, MD, PhD, Anil Potti, M.D., John D Shaughnessy, Jr., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 1833.
https://doi.org/10.1182/blood.V114.22.1833.1833
Published: 2009